Show simple item record

dc.contributor.advisorRice, Laurence
dc.contributor.authorPutnam, Marshall Ray
dc.date.accessioned2015-08-27T16:26:14Z
dc.date.available2015-08-27T16:26:14Z
dc.date.issued1982-05-01
dc.identifier.urihttps://hdl.handle.net/11244/16615
dc.description.abstractThis study was done for Boehringer Ingelheim Inc. Boehringer Ingelheim Inc. is submitting this drug to the United States Department of Food and Drug Administration for use in the United States. The primary objective is to document efficacy reported in European studies.
dc.formatapplication/pdf
dc.languageen_US
dc.publisherOklahoma State University
dc.rightsCopyright is held by the author who has granted the Oklahoma State University Library the non-exclusive right to share this material in its institutional repository. Contact Digital Library Services at lib-dls@okstate.edu or 405-744-9161 for the permission policy on the use, reproduction or distribution of this material.
dc.titleNab 365 (Clenbuterol, Planipart TM) for the Postponement of Parturition and Alleviation of Dystocia in Cattle
dc.typetext
dc.contributor.committeeMemberStratton, Louie S.
osu.filenameThesis-1982-P989n.pdf
osu.accesstypeOpen Access
dc.description.departmentPhysiology
dc.type.genreThesis


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record